Kodiak Sciences Inc.
NASDAQ:KOD · NASDAQ Global Market
-$0.03 today
Vol 1.21M · Avg 1.10M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+895.59%
Period High
$46.44
Period Low
$3.61
Latest
$36.14
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Tango Therapeutics, Inc.
NASDAQ:TNGX
$3.59B
AnaptysBio, Inc.
NASDAQ:ANAB
$2.39B
UroGen Pharma Ltd.
NASDAQ:URGN
$1.59B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$1.49B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.13B
Xencor, Inc.
NASDAQ:XNCR
$928.99M
Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
$856.01M
Oculis Holding AG
NASDAQ:OCS
$636.87M
BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOT
$610.02M
ProKidney Corp.
NASDAQ:PROK
$263.28M
What is the latest KOD filing?
The latest filing shown is 4 dated Jun 5, 2026.
How many recent filings does KOD have?
Intrinsic Alpha currently shows 20 recent filings for KOD.
Explore More
Continue the stock analysis
Jump to another research area for this company.